Ichiki M - Search Results

1

Prognostic significance of febrile episodes in lung cancer patients receiving chemotherapy.

Rikimaru T, Ichiki M, Ookubo Y, Matumoto K, Mimori Y, Sueyasu Y, Kinoshita M, Yano H, Shiraishi T, Oizumi K. Rikimaru T, et al. Among authors: ichiki m. Support Care Cancer. 1998 Jul;6(4):396-401. doi: 10.1007/s005200050183. Support Care Cancer. 1998. PMID: 9695209

2

[Inflammatory reactions and microorganisms cultured from sputum and blood in association with terminal stage infection of patients with lung cancer].

Rikimaru T, Mimori K, Ichiki M, Ookubo Y, Mitsui T, Sueyasu M, Hotta M, Kinoshita M, Mastunami M, Oizumi K. Rikimaru T, et al. Among authors: ichiki m. Kansenshogaku Zasshi. 1998 Feb;72(2):123-7. doi: 10.11150/kansenshogakuzasshi1970.72.123. Kansenshogaku Zasshi. 1998. PMID: 9545687 Japanese.

3

Phase II study of irinotecan and ifosfamide in patients with advanced non-small cell lung cancer.

Ichiki M, Rikimaru T, Gohara R, Koga T, Kawayama T, Matunami M, Oshita Y, Kamimura T, Aizawa H. Ichiki M, et al. Oncology. 2003;64(4):306-11. doi: 10.1159/000070286. Oncology. 2003. PMID: 12759525 Clinical Trial.

4

Combination chemotherapy with irinotecan and ifosfamide as second-line treatment of refractory or sensitive relapsed small cell lung cancer: a phase II study.

Ichiki M, Gohara R, Rikimaru T, Kitajima T, Fujiki R, Shimada A, Aizawa H. Ichiki M, et al. Chemotherapy. 2003 Jul;49(4):200-5. doi: 10.1159/000071145. Chemotherapy. 2003. PMID: 12886056 Clinical Trial.

5

Cyfra 21-1 as a marker of lung cancer.

Kinoshita M, Watanabe H, Ichiki M, Sumita S, Okubo Y, Matsunami M, Furuno H, Shiraishi T, Rikimaru T, Oizumi K. Kinoshita M, et al. Among authors: ichiki m. Kurume Med J. 1998;45(1):7-9. doi: 10.2739/kurumemedj.45.7. Kurume Med J. 1998. PMID: 9658744 Free article.

6

[Clinical features and outcome of pneumonia in patients with lung cancer].

Rikimaru T, Matsumoto K, Koga T, Ichiki M, Kinosita M, Oizumi K. Rikimaru T, et al. Among authors: ichiki m. Nihon Kokyuki Gakkai Zasshi. 1999 Apr;37(4):282-6. Nihon Kokyuki Gakkai Zasshi. 1999. PMID: 10390965 Japanese.

7

Phase I study of a combination of irinotecan and ifosfamide in advanced primary lung cancer.

Ichiki M, Rikimaru T, Okubo Y, Gohara R, Mitui T, Kawayama T, Kinoshita M, Oizumi K. Ichiki M, et al. Kurume Med J. 1999;46(2):111-5. doi: 10.2739/kurumemedj.46.111. Kurume Med J. 1999. PMID: 10410530 Free article. Clinical Trial.

8

[Immunodeficiency induced by antineoplastic agents].

Ichiki M, Rikimaru T, Oizumi K. Ichiki M, et al. Ryoikibetsu Shokogun Shirizu. 2000;(32):433-5. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11212767 Review. Japanese. No abstract available.

9

Phase I and pharmacokinetic study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer.

Ichiki M, Gohara R, Fujiki R, Hoashi S, Rikimaru T, Aizawa H. Ichiki M, et al. Cancer Chemother Pharmacol. 2003 Jul;52(1):67-72. doi: 10.1007/s00280-003-0627-7. Epub 2003 May 13. Cancer Chemother Pharmacol. 2003. PMID: 12743738 Clinical Trial.

10

[Phase I study of biweekly paclitaxel and carboplatin administration in patients with advanced non-small cell lung cancer].

Ichiki M, Rikimaru T, Gohara R, Oshita Y, Kamimura T, Hoashi S, Koga T, Aizawa H. Ichiki M, et al. Gan To Kagaku Ryoho. 2002 Aug;29(8):1389-94. Gan To Kagaku Ryoho. 2002. PMID: 12214466 Clinical Trial. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters